{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:13Z","timestamp":1787004793381,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1053\/j.akdh.2024.03.007","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T06:42:58Z","timestamp":1725259378000},"page":"450-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Electrolyte and Acid-Base Abnormalities After Kidney Transplantation"],"prefix":"10.1053","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1611-6342","authenticated-orcid":false,"given":"Patricia","family":"Nogueira de Sa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-7617","authenticated-orcid":false,"given":"Mohanram","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann C.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.akdh.2024.03.007_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trre.2015.05.002","article-title":"Hypomagnesaemia in kidney transplantation","volume":"29","author":"Van Laecke","year":"2015","journal-title":"Transplant Rev"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.007_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/17843286.2018.1549193","article-title":"Electrolytes disturbances after kidney transplantation","volume":"74","author":"De Waele","year":"2019","journal-title":"Acta Clin Belg"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.007_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/oxfordjournals.ndt.a092279","article-title":"Skeletal muscle magnesium content during cyclosporin and azathioprine treatment in renal transplant recipients","volume":"8","author":"Frost","year":"1993","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"10.1053\/j.akdh.2024.03.007_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.amjmed.2013.02.036","article-title":"Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease","volume":"126","author":"Laecke","year":"2013","journal-title":"Am J Med"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.007_bib5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ki.2014.331","article-title":"Results from the Atherosclerosis risk in communities study suggest that low serum magnesium is associated with incident kidney disease","volume":"87","author":"Tin","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.007_bib6","doi-asserted-by":"crossref","first-page":"F486","DOI":"10.1152\/ajprenal.00116.2011","article-title":"Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment","volume":"301","author":"Ledeganck","year":"2011","journal-title":"Am J Physiol Ren Physiol"},{"issue":"9308","key":"10.1053\/j.akdh.2024.03.007_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.akdh.2024.03.007_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fmed.2018.00261","article-title":"Electrolyte and acid-base disorders in the renal transplant recipient","volume":"5","author":"Pochineni","year":"2018","journal-title":"Front Med"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.007_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.09470819","article-title":"Electrolyte disorders in kidney transplantation","volume":"15","author":"Miles","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.007_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00007890-200202150-00005","article-title":"Role of hypomagnesemia in chronic cyclosporine nephropathy","volume":"73","author":"Miura","year":"2002","journal-title":"Transplantation"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.007_bib11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/00007890-200209270-00009","article-title":"Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism","volume":"74","author":"Asai","year":"2002","journal-title":"Transplantation"},{"issue":"7","key":"10.1053\/j.akdh.2024.03.007_bib12","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/ndt\/gfq728","article-title":"The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients","volume":"26","author":"Van Laecke","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.007_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.185","article-title":"Early initiation of sodium-glucose linked transporter inhibitors (SGLT-2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients","volume":"4","author":"Song","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.007_bib14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/ckj\/sfad007","article-title":"Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study","volume":"16","author":"S\u00e1nchez Fructuoso","year":"2023","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.007_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2021.100611","article-title":"Management of hyperkalemia: a focus on kidney transplant recipients","volume":"35","author":"Almalki","year":"2021","journal-title":"Transplant Rev"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.007_bib16","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1210\/endo.143.5.8821","article-title":"Cyclosporine A and FK506 inhibit transcriptional activity of the Human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation","volume":"143","author":"Deppe","year":"2002","journal-title":"Endocrinology"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.007_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1399-0012.2003.00154.x","article-title":"Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression","volume":"18","author":"Heering","year":"2004","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1053\/j.akdh.2024.03.007_bib18","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/nm.2497","article-title":"The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension","volume":"17","author":"Hoorn","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.007_bib19","first-page":"69","article-title":"Safety and efficacy of patiromer in kidney and liver transplant recipients","volume":"8","author":"Servais","year":"2022","journal-title":"J Clin Nephrol Ren Care"},{"issue":"9","key":"10.1053\/j.akdh.2024.03.007_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000002829","article-title":"Safety, effectiveness, and tolerability of patiromer in kidney transplant recipients","volume":"103","author":"Lim","year":"2019","journal-title":"Transplantation"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.007_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ckj\/sfac205","article-title":"A Phase 1, open-label, crossover study evaluating the effect of a single dose of sodium zirconium cyclosilicate on the pharmacokinetics of tacrolimus and cyclosporin","volume":"16","author":"N\u00e5g\u00e5rd","year":"2022","journal-title":"Clin Kidney J"},{"issue":"10376","key":"10.1053\/j.akdh.2024.03.007_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(22)02606-X","article-title":"Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Mohebbi","year":"2023","journal-title":"Lancet"},{"key":"10.1053\/j.akdh.2024.03.007_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.12659\/AOT.892320","article-title":"Renal tubular acidosis in renal transplant patients: the effect of immunosuppressive drugs","volume":"20","author":"Tanrisev","year":"2015","journal-title":"Ann Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.007_bib24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1159\/000510158","article-title":"Causes and consequences of metabolic acidosis in patients after kidney transplantation","volume":"45","author":"Ritter","year":"2020","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.007_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1399-0012.1998.tb00998.x","article-title":"Distal tubular acidosis induced by FK506","volume":"12","author":"Heering","year":"1998","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.007_bib26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5049\/EBP.2007.5.2.126","article-title":"Electrolyte and acid-base disturbances induced by Clacineurin inhibitors","volume":"5","author":"Lee","year":"2007","journal-title":"Electrolyte Blood Press"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.007_bib27","doi-asserted-by":"crossref","first-page":"F499","DOI":"10.1152\/ajprenal.90489.2008","article-title":"The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins","volume":"297","author":"Mohebbi","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"10.1053\/j.akdh.2024.03.007_bib28","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2215\/CJN.04590512","article-title":"Dietary acid load and metabolic acidosis in renal transplant recipients","volume":"7","author":"van den Berg","year":"2012","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.007_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ki.2010.388","article-title":"Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans","volume":"79","author":"Raphael","year":"2011","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.007_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","article-title":"Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"62","author":"Dobre","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.007_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.ajkd.2009.02.014","article-title":"Serum bicarbonate levels and the progression of kidney disease: a cohort study","volume":"54","author":"Shah","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.007_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40620-019-00656-5","article-title":"Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study","volume":"32","author":"Di Iorio","year":"2019","journal-title":"J Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.007_bib33","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1681\/ASN.2016070793","article-title":"Metabolic acidosis and long-term clinical outcomes in kidney transplant recipients","volume":"28","author":"Park","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2024.03.007_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000910","article-title":"Effect of sodium bicarbonate in kidney transplant recipients with chronic metabolic acidosis","volume":"5","author":"Schulte","year":"2019","journal-title":"Transplant Direct"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.007_bib36","first-page":"89","article-title":"Calcium metabolism in the early post-transplant period","volume":"63","author":"Evenepoel","year":"2011","journal-title":"Minerva Urol E Nefrol Ital J Urol Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.007_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.transproceed.2007.03.025","article-title":"Calcium and phosphorus metabolism disturbances after renal transplantation","volume":"39","author":"Ramezani","year":"2007","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.007_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/ctr.12291","article-title":"Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice","volume":"28","author":"Muirhead","year":"2014","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.007_bib39","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","article-title":"Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study","volume":"19","author":"Evenepoel","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.007_bib40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40265-019-01074-4","article-title":"Management of post-transplant hyperparathyroidism and bone disease","volume":"79","author":"Delos Santos","year":"2019","journal-title":"Drugs"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.007_bib41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1399-3062.2011.00623.x","article-title":"Hypercalcemia and pneumocystis Pneumonia after kidney transplantation: report of an exceptional case and literature review","volume":"13","author":"Chatzikyrkou","year":"2011","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1053\/j.akdh.2024.03.007_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5694\/mja2.51761","article-title":"Hypercalcaemia in an immunocompromised patient: consider Pneumocystis jirovecii pneumonia","volume":"217","author":"Bromley","year":"2022","journal-title":"Med J Aust"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.007_bib43","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x202010558","article-title":"Causes of hypercalcemia in renal transplant recipients: persistent hyperparathyroidism and others","volume":"54","author":"Moyses-Neto","year":"2021","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.007_bib44","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1523-1755.2005.00303.x","article-title":"Clinical impact of preexisting vascular calcifications on mortality after renal transplantation","volume":"67","author":"Hern\u00e1ndez","year":"2005","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.007_bib45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/TP.0000000000000583","article-title":"Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism","volume":"99","author":"Pihlstr\u00f8m","year":"2015","journal-title":"Transplantation"},{"issue":"7","key":"10.1053\/j.akdh.2024.03.007_bib46","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1034\/j.1600-6143.2003.00131.x","article-title":"Post transplant erythrocytosis in hypercalcemic renal transplant recipients","volume":"3","author":"Kurella","year":"2003","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.007_bib47","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.surg.2017.12.010","article-title":"Persistent hyperparathyroidism as a risk factor for long-term graft failure: the need to discuss indication for parathyroidectomy","volume":"163","author":"Araujo","year":"2018","journal-title":"Surgery"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.007_bib48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.surg.2022.07.031","article-title":"Hyperparathyroidism at 1 year after kidney transplantation is associated with graft loss","volume":"173","author":"Crepeau","year":"2023","journal-title":"Surgery"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.007_bib49","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1600-6143.2005.00938.x","article-title":"Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications","volume":"5","author":"Gwinner","year":"2005","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1053\/j.akdh.2024.03.007_bib50","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1600-6143.2008.02327.x","article-title":"Effect of teriparatide on early bone loss after kidney transplantation","volume":"8","author":"Cejka","year":"2008","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.007_bib51","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2015060622","article-title":"A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism","volume":"27","author":"Cruzado","year":"2016","journal-title":"J Am Soc Nephrol JASN"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.007_bib52","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00268-019-05020-z","article-title":"Cardiovascular and cerebrovascular events after parathyroidectomy in patients on renal replacement therapy","volume":"43","author":"Ivarsson","year":"2019","journal-title":"World J Surg"},{"issue":"11","key":"10.1053\/j.akdh.2024.03.007_bib53","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/ajt.12911","article-title":"A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism","volume":"14","author":"Evenepoel","year":"2014","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.007_bib54","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2015121349","article-title":"Parathyroidectomy or calcimimetic to Treat hypercalcemia after kidney transplantation?","volume":"27","author":"Fukagawa","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.007_bib55","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.transproceed.2011.12.050","article-title":"Clinical manifestations of hypercalcemia and hypophosphatemia after kidney transplantation","volume":"44","author":"Kim","year":"2012","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.007_bib56","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2215\/CJN.01310308","article-title":"Recovery of hyperphosphatoninism and renal phosphorus wasting one Year after Successful renal transplantation","volume":"3","author":"Evenepoel","year":"2008","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.007_bib57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/TP.0000000000000823","article-title":"A prospective cohort study of mineral metabolism after kidney transplantation","volume":"100","author":"Wolf","year":"2016","journal-title":"Transplantation"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.007_bib58","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.ki.5001788","article-title":"Post-transplant hypophosphatemia: Tertiary \u201cHyper-Phosphatoninism\u201d?","volume":"70","author":"Bhan","year":"2006","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.007_bib59","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1600-6143.2007.01753.x","article-title":"Tertiary \u201chyperphosphatoninism\u201d accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients","volume":"7","author":"Evenepoel","year":"2007","journal-title":"Am J Transplant"},{"issue":"5-6","key":"10.1053\/j.akdh.2024.03.007_bib60","first-page":"333","article-title":"Hypophosphatemia in long-term renal transplant recipients: effects on bone histology and 1,25-dihydroxycholecalciferol","volume":"12","author":"Felsenfeld","year":"1986","journal-title":"Miner Electrolyte Metab"},{"issue":"11","key":"10.1053\/j.akdh.2024.03.007_bib61","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrneph.2015.153","article-title":"Phosphate and FGF-23 homeostasis after kidney transplantation","volume":"11","author":"Baia","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.007_bib62","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1046\/j.1523-1755.2001.0600031182.x","article-title":"Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia","volume":"60","author":"Green","year":"2001","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.007_bib63","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1530\/EJE-10-1150","article-title":"Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels","volume":"164","author":"Trombetti","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.007_bib64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MOP.0000000000000715","article-title":"Pathogenesis and treatment of electrolyte problems post transplant","volume":"31","author":"Kim","year":"2019","journal-title":"Curr Opin Pediatr"},{"key":"10.1053\/j.akdh.2024.03.007_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/379082","article-title":"FGF-23 levels before and after renal transplantation","volume":"2009","author":"Economidou","year":"2009","journal-title":"J Transplant"},{"issue":"9","key":"10.1053\/j.akdh.2024.03.007_bib66","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.transproceed.2012.09.070","article-title":"Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation","volume":"44","author":"S\u00e1nchez Fructuoso","year":"2012","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.007_bib67","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.transproceed.2005.12.083","article-title":"Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation","volume":"38","author":"Falkiewicz","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1053\/j.akdh.2024.03.007_bib68","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/906832","article-title":"Clinical impact of hypercalcemia in kidney transplant","volume":"2011","author":"Messa","year":"2011","journal-title":"Int J Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.007_bib69","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.transproceed.2011.11.046","article-title":"Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia","volume":"44","author":"Han","year":"2012","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.007_bib70","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bone.2012.06.027","article-title":"Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation","volume":"51","author":"Tomida","year":"2012","journal-title":"Bone"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.007_bib71","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/TP.0b013e318264fc08","article-title":"Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients","volume":"94","author":"Barros","year":"2012","journal-title":"Transplantation"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T12:13:10Z","timestamp":1732709590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813924000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2949813924000570"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2024.03.007","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrolyte and Acid-Base Abnormalities After Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2024.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}